Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Annual Review of Biomedical Engineering is Scopus-indexed (Q1, CiteScore 18.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Annual Reviews Inc..
Checked against the index lists dated .
ISSN 1523-9829Verify ISSN ↗1545-4274Verify ISSN ↗
Publisher: Annual Reviews Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 9 / 466 | 98th | Q1 |
| Biomedical Engineering | 16 / 342 | 95th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1999–present, best quartile Q1, CiteScore 18.8.
Annual Review of Biomedical Engineering is Q1 in Medicine (miscellaneous) (rank 9 of 466) and Q1 in Biomedical Engineering (rank 16 of 342), by CiteScore 2025.
Annual Review of Biomedical Engineering is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 18.8, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.856, quartile Q1, with an H-index of 166.
Annual Review of Biomedical Engineering is published by Annual Reviews Inc. Its print ISSN is 1523-9829 and its online ISSN is 1545-4274.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Annual Review of Biomedical Engineering has an h-index of 176 and a 2-year mean of 15.17 citations per paper (OpenAlex). Its Scopus CiteScore is 18.8, quartile Q1. On 2-year citations it ranks #3 of 451 Scopus journals in Medicine (miscellaneous).
Annual Review of Biomedical Engineering published 21 papers in 2025; its busiest recent year was 2021 with 24. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2021–2026), authors are most often from United States (80.4%), Canada (2.2%) and Italy (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.